Ameriprise Financial Inc Caladrius Biosciences, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$3.49 - $5.77 $51,194 - $84,640
-14,669 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$4.85 - $6.5 $15,102 - $20,241
-3,114 Reduced 17.51%
14,669 $87,000
Q2 2018

Aug 14, 2018
SELL
$3.8 - $8.64 $40,618 - $92,352
-10,689 Reduced 37.54%
17,783 $115,000
Q1 2018

May 15, 2018
BUY
$3.7 - $6.09 $105,346 - $173,394
28,472 New
28,472 $175,000

About CALADRIUS BIOSCIENCES, INC.

CLBS Quotes by TradingView
  • Ticker CLBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,583,200
  • Market Cap $25.8M
  • Description
  • Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...
More about CLBS
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email